Among the eight key candidates linked to the EGFR‐centered interactome, HSP90AB1 showed a clear and statistically significant elevation in metastatic tumors, while the others displayed similar but non‐significant upward trends. This evidence concerns the gene HSP90AB1 and metastatic neoplasm.